{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:22:30Z","timestamp":1784604150951,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.ejogrb.2005.09.010","type":"journal-article","created":{"date-parts":[[2005,10,21]],"date-time":"2005-10-21T07:13:45Z","timestamp":1129878825000},"page":"73-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Use of low-molecular-weight heparin from the first trimester of pregnancy: A retrospective study of 111 consecutive pregnancies"],"prefix":"10.1016","volume":"127","author":[{"given":"Philippe","family":"Deruelle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Denervaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hachulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Ducloy-Bouthors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sylvie","family":"Valat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Puech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Trillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Hatron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Subtil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejogrb.2005.09.010_bib1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0889-8545(05)70319-3","article-title":"Current concepts of anticoagulant therapy in pregnancy","volume":"24","author":"Barbour","year":"1997","journal-title":"Obstet Gynecol Clin N Am"},{"issue":"5","key":"10.1016\/j.ejogrb.2005.09.010_bib2","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0889-8588(05)70175-1","article-title":"Antithrombotic therapy in high-risk pregnancy","volume":"14","author":"Heilmann","year":"2000","journal-title":"Hematol Oncol Clin N Am"},{"issue":"4","key":"10.1016\/j.ejogrb.2005.09.010_bib3","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1055\/s-0038-1657712","article-title":"Risk factors for pregnancy associated venous thromboembolism","volume":"78","author":"McColl","year":"1997","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.ejogrb.2005.09.010_bib4","first-page":"620","article-title":"Thromboembolism and pregnancy","volume":"82","author":"Ginsberg","year":"1999","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.ejogrb.2005.09.010_bib5","first-page":"243","article-title":"Absence of transplacental passage of the low molecular weight heparin enoxaparin","volume":"30","author":"Dimitrakakis","year":"2000","journal-title":"Haemostasis"},{"issue":"5","key":"10.1016\/j.ejogrb.2005.09.010_bib6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1055\/s-0037-1613894","article-title":"Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin","volume":"83","author":"Brenner","year":"2000","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.ejogrb.2005.09.010_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0049-3848(00)00413-8","article-title":"Effect of thrombophylaxis on uterine and fetal circulation in pregnant women with a history of pregnancy complications","volume":"101","author":"Bar","year":"2001","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.ejogrb.2005.09.010_bib8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0301-2115(99)00008-1","article-title":"Anticoagulant therapy in pregnancy","volume":"83","author":"Robin","year":"1999","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.ejogrb.2005.09.010_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-0038-1646526","article-title":"Low molecular weight heparin Novo (LHN-1) does not cross the placenta during the second trimester of pregnancy","volume":"61","author":"Omri","year":"1989","journal-title":"Thromb Haemost"},{"issue":"20","key":"10.1016\/j.ejogrb.2005.09.010_bib10","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin","volume":"332","author":"Warkentin","year":"1995","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ejogrb.2005.09.010_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0301-2115(95)02358-5","article-title":"Bone density studies in pregnant women receiving heparin","volume":"65","author":"Shefras","year":"1996","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"10.1016\/j.ejogrb.2005.09.010_bib12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0049-3848(99)00110-3","article-title":"Thromboprophylaxis with low molecular weight heparin (dalteparin) in pregnancy","volume":"96","author":"Pettila","year":"1999","journal-title":"Thromb Res"},{"issue":"5","key":"10.1016\/j.ejogrb.2005.09.010_bib13","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1055\/s-0037-1614550","article-title":"Safety of low-molecular-weight heparin in pregnancy: a systematic review","volume":"81","author":"Sanson","year":"1999","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.ejogrb.2005.09.010_bib14","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0002-9378(97)70403-4","article-title":"Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk","volume":"176","author":"Nelson-Piercy","year":"1997","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2005.09.010_bib15","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1055\/s-0038-1646338","article-title":"Use of low molecular weight heparin in pregnancy","volume":"68","author":"Melissari","year":"1992","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.ejogrb.2005.09.010_bib16","first-page":"1","article-title":"Thromboprophylaxis with low molecular mass heparin, \u2018Fragmin\u2019 (dalteparin), during pregnancy\u2014a longitudinal safety study","volume":"9","author":"Blomback","year":"1998","journal-title":"Blood Coagul Fibrinol"},{"issue":"1","key":"10.1016\/j.ejogrb.2005.09.010_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-0038-1655903","article-title":"Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies","volume":"77","author":"Hunt","year":"1997","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.ejogrb.2005.09.010_bib18","first-page":"391","article-title":"The weight and size of newborn infants at birth","volume":"66","author":"Leroy","year":"1971","journal-title":"Rev Fr Gynecol Obstet"},{"issue":"11","key":"10.1016\/j.ejogrb.2005.09.010_bib19","first-page":"1134","article-title":"Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies","volume":"108","author":"Lepercq","year":"2001","journal-title":"Br J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2005.09.010_bib20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-3016.1994.tb00436.x","article-title":"Vaginal bleeding and adverse reproductive outcomes: a meta-analysis","volume":"8","author":"Ananth","year":"1994","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"1 Suppl.","key":"10.1016\/j.ejogrb.2005.09.010_bib21","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.1378\/chest.119.1_suppl.122S","article-title":"Use of antithrombotic agents during pregnancy","volume":"119","author":"Ginsberg","year":"2001","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ejogrb.2005.09.010_bib22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1055\/s-0038-1647659","article-title":"Subcutaneous heparin therapy during pregnancy: a need for concern at the time of delivery","volume":"65","author":"Anderson","year":"1991","journal-title":"Thromb Haemost"},{"issue":"20","key":"10.1016\/j.ejogrb.2005.09.010_bib23","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1056\/NEJM200011163432002","article-title":"Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of clot in this Pregnancy Study Group","volume":"343","author":"Brill-Edwards","year":"2000","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ejogrb.2005.09.010_bib24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00006254-199904000-00023","article-title":"Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation","volume":"54","author":"Ray","year":"1999","journal-title":"Obstet Gynecol Surv"},{"issue":"3","key":"10.1016\/j.ejogrb.2005.09.010_bib25","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-2141.1997.882901.x","article-title":"Activated protein C resistance can be associated with recurrent fetal loss","volume":"97","author":"Brenner","year":"1997","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.ejogrb.2005.09.010_bib26","first-page":"464","article-title":"Birth weight percentile and perinatal outcome: recurrence of intrauterine growth retardation","volume":"68","author":"Patterson","year":"1986","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2005.09.010_bib27","first-page":"40","article-title":"Early fetal growth retardation: obstetric background and recurrence rate","volume":"67","author":"Visser","year":"1986","journal-title":"Obstet Gynecol"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211505005063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211505005063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:15:37Z","timestamp":1759554937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211505005063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0301211505005063"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2005.09.010","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of low-molecular-weight heparin from the first trimester of pregnancy: A retrospective study of 111 consecutive pregnancies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2005.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}